» Articles » PMID: 9235916

P110delta, a Novel Phosphatidylinositol 3-kinase Catalytic Subunit That Associates with P85 and is Expressed Predominantly in Leukocytes

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1997 Aug 1
PMID 9235916
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

We have identified a novel p110 isoform of phosphatidylinositol 3-kinase from human leukocytes that we have termed p110delta. In addition, we have independently isolated p110delta from a mouse embryo library on the basis of its ability to interact with Ha-RasV12 in the yeast two-hybrid system. This unique isoform contains all of the conserved structural features characteristic of the p110 family. Recombinant p110delta phosphorylates phosphatidylinositol and coimmunoprecipitates with p85. However, in contrast to previously described p110 subunits, p110delta is expressed in a tissue-restricted fashion; it is expressed at high levels in lymphocytes and lymphoid tissues and may therefore play a role in phosphatidylinositol 3-kinase-mediated signaling in the immune system.

Citing Articles

Hyperactivation of the PI3K pathway in inborn errors of immunity: current understanding and therapeutic perspectives.

IJspeert H, Dalm V, van Zelm M, Edwards E Immunother Adv. 2024; 4(1):ltae009.

PMID: 39679264 PMC: 11638974. DOI: 10.1093/immadv/ltae009.


Diacylglycerol kinase is a keystone regulator of signaling relevant to the pathophysiology of asthma.

Hernandez-Lara M, Richard J, Deshpande D Am J Physiol Lung Cell Mol Physiol. 2024; 327(1):L3-L18.

PMID: 38742284 PMC: 11380957. DOI: 10.1152/ajplung.00091.2024.


PI3Kγδ inhibition suppresses key disease features in a rat model of asthma.

Pinkerton J, Preite S, Piras A, Zervas D, Markou T, Freeman M Respir Res. 2024; 25(1):175.

PMID: 38654248 PMC: 11040934. DOI: 10.1186/s12931-024-02814-1.


A combined opposite targeting of p110δ PI3K and RhoA abrogates skin cancer.

Tzenaki N, Xenou L, Goulielmaki E, Tsapara A, Voudouri I, Antoniou A Commun Biol. 2024; 7(1):26.

PMID: 38182748 PMC: 10770346. DOI: 10.1038/s42003-023-05639-8.


Modulating the PI3K Signalling Pathway in Activated PI3K Delta Syndrome: a Clinical Perspective.

Berglund L J Clin Immunol. 2023; 44(1):34.

PMID: 38148368 PMC: 10751257. DOI: 10.1007/s10875-023-01626-0.